[ad_1]
Lexama Bioscience Corp. (CSE: LXX) President and CEO Chris Bunka has joined Steve Darling of Proactive Investors Vancouver on Skype to announce to the company its agreement on a five-year contract that will allow Universal Hemp's use their DehydraTECH technology.
This agreement will work under a royalty agreement, but the terms of this part of the agreement are not disclosed, but the agreement is worth at least $ 3.75 million.
Source link
